Financials
- Financial year
- 2025
- Total assets
- €543,470
- Solvency
- 2.4%
- Liquidity
- 1.09
Total assets▲ 38.1%
Net result
20222025
Summary
GREZ-DOICEAU OPHTALMOLOGY has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €13,194. Equity is shrinking by about 12% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Activity not known1 site
Size
€543,470total assets 2025
- Equity
- €13,194
Turnover not published (micro format)
Financial health
- Bankruptcy probabilitywithin 12 months
- 0.6%
Too few figures to score
Structure
2025 accounts filed 74 days late1 deed in the Belgian Official Gazette
Signalsraises riskLast filed accounts filed 74 days late; 1 of the last 3 lateFounded in 2021lowers riskSize: total assets €543,470No main activity registeredGrowing equityneutralA punctual record breaksShow the evidence
Bankruptcy probability
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%
12-2024: 0.3%● unchanged vs 11-2024
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025lowest value
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025
08-2025: 0.5%▲ +0.2 percentage points vs 07-2025
09-2025: 0.3%▼ -0.2 percentage points vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.4%▲ +0.1 percentage points vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.6%▲ +0.2 percentage points vs 07-2026
09-2026: 0.7%▲ +0.1 percentage points vs 08-2026highest value
10-2026: 0.6%▼ -0.1 percentage points vs 09-2026
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
22232425
2022 to 2025 · latest year €13,194
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-10-2026, 74 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 4 filingsDeviation from the deadline
2025
74 days late
2024
2 days early
2023
5 days early
2022
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 4 accounts on average 17 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · micro…
- Annual accounts filedfinancial year 2024 · micro…
- Liquidity more than doubledcurrent ratio 1.33
Key points
By topic
Timeline
- Events
- 6
- Since
- 2023
- Next accounts
- by 31-07-2027
- 26-07-2024Annual accounts filed
- 31-12-2023Weakest financial year
- 31-07-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 31-03-2021
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about GREZ-DOICEAU OPHTALMOLOGY
- What is the company number of GREZ-DOICEAU OPHTALMOLOGY?
- 0765.943.177. In Belgium the VAT number is the company number with BE in front: BE 0765.943.177.
- Where is GREZ-DOICEAU OPHTALMOLOGY based?
- The registered office is at Chaussée de Wavre 179-181, 1390 Grez-Doiceau.Company details
- What is the legal form of GREZ-DOICEAU OPHTALMOLOGY?
- Private limited company (BV).
- When was GREZ-DOICEAU OPHTALMOLOGY founded?
- On 31-03-2021.
- Is GREZ-DOICEAU OPHTALMOLOGY still active?
- Yes, GREZ-DOICEAU OPHTALMOLOGY is an active enterprise in the KBO register.
- What is the turnover of GREZ-DOICEAU OPHTALMOLOGY?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is GREZ-DOICEAU OPHTALMOLOGY profitable?
- In financial year 2024, GREZ-DOICEAU OPHTALMOLOGY made a profit of €3,547.
- Where can I find the annual accounts of GREZ-DOICEAU OPHTALMOLOGY?
- GREZ-DOICEAU OPHTALMOLOGY filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of GREZ-DOICEAU OPHTALMOLOGY due?
- By 31-07-2027, for financial year 2026.Timeline
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.